Topical Agents in the Treatment of Rheumatic Pain

Rheumatic Disease Clinics of North America

Volumn 34, Issue 2, 2008, Pages 415-432

  Moore, R Andrew ^a   Derry, Sheena ^a   McQuay, Henry J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BENZYDAMINE; CAPSAICIN; DICLOFENAC; FELBINAC; FLURBIPROFEN; GLYCOSAMINOGLYCAN POLYSULFATE; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLACEBO; RUBEFACIENT; SALICYLAMIDE; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ANALGESIA; APPLICATION SITE REACTION; CHRONIC PAIN; CLINICAL TRIAL; COUGHING; DIABETIC NEUROPATHY; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG WITHDRAWAL; DRY SKIN; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; HUMAN; KNEE OSTEOARTHRITIS; MUSCLE STRAIN; MUSCULOSKELETAL PAIN; NEUROPATHIC PAIN; OSTEOARTHRITIS; PAIN ASSESSMENT; PHOTODERMATOSIS; PHOTOTOXICITY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; RHEUMATIC DISEASE; SIDE EFFECT; SKIN PENETRATION; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPSAICIN; CLINICAL TRIALS AS TOPIC; HUMANS; IRRITANTS; PAIN; RHEUMATIC DISEASES; SENSORY SYSTEM AGENTS;

EID: 47249107258     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2008.03.006     Document Type: Review

References (47)

1. Osteoarthritis: the care and management of osteoarthritis in adults (2008), Royal College of Physicians, London
2. Zhang W., Doherty M., Leeb B.F., et al. EULAR evidence based recommendations for the diagnosis of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66 (2007) 377-388
3. Zhang W., Moskowitz R.W., Nuki G., et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16 (2008) 137-162
4. British National Formulary. March 2006. p. 531.
5. Li Wan Po A. Topical analgesics. PJ practice checklist. The Pharmaceutical Journal (2006)
6. Mason L., Moore R.A., Edwards J.E., et al. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ 328 (2004) 995-998
7. McQuay H.J., and Moore R.A. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 126 (1997) 712-720
8. Mason L., Moore R.A., Derry S., et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328 (2004) 991-994
9. Mason L., Moore R.A., Edwards J.E., et al. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 5 (2004) 28
10. Moore R.A., Tramèr M.R., Carroll D., et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316 (1998) 333-338
11. Lin J., Zhang W., Jones A., et al. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329 (2004) 324-327
12. McQuay H., Carroll D., and Moore A. Variation in the placebo effect in randomised controlled trials of analgesics: all is as blind as it seems. Pain 64 (1996) 331-335
13. Bookman A.A., Williams K.S., and Shainhouse J.Z. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 171 (2004) 333-338
14. Roth S.H., and Shainhouse J.Z. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med 164 (2004) 2017-2023
15. Tugwell P.S., Wells G.A., and Shainhouse J.Z. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol 31 (2004) 2002-2012
16. Baer P.A., Thomas L.M., and Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord 6 (2005) 44
17. Niethard F.U., Gold M.S., Solomon G.S., et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol 32 (2005) 2384-2392
18. Brühlmann P., de Vathaire F., Dreiser R.L., et al. Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studies. Curr Med Res Opin 22 (2006) 2429-2438
19. Towheed T.E. Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials. J Rheumatol 33 (2006) 567-573
20. Pham T., van der Heijde D., Lassere M., et al. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. J Rheumatol 30 (2003) 1648-1654
21. Evans J.M., McMahon A.D., McGilchrist M.M., et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 311 (1995) 22-26
22. Evans J.M., McGregor E., McMahon A.D., et al. Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM 88 (1995) 551-557
23. Albès B., Marguery M.C., Schwarze H.P., et al. Prolonged photosensitivity following contact photoallergy to ketoprofen. Dermatology 201 (2000) 171-174
24. Bagheri H., Lhiaubet V., Montastruc J.L., et al. Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data. Drug Saf 22 (2000) 339-349
25. Mason L., Moore R.A., Edwards J.E., et al. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 5 (2004) 10
26. Kreilgaard M. Assessment of cutaneous drug delivery using microdialysis. Adv Drug Deliv Rev. 54 Suppl 1 (2002) S99-S121
27. Sloan K.B., and Wasdo S. Designing for topical delivery: prodrugs can make the difference. Med Res Rev 23 (2003) 763-793
28. Dehghanyar P., Mayer B.X., Namiranian K., et al. Topical skin penetration of diclofenac after single- and multiple-dose application. Int J Clin Pharmacol Ther 42 (2004) 353-359
29. Higaki K., Nakayama K., Suyama T., et al. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 288 (2005) 227-233
30. Roberts M.S., and Cross S.E. A physiological pharmacokinetic model for solute disposition in tissues below a topical application site. Pharm Res 16 (1999) 1392-1398
31. Roberts M.S., and Cross S.E. Percutaneous absorption of topically applied NSAIDs and other compounds: role of solute properties, skin physiology and delivery systems. Inflammopharmacology 7 (1999) 339-350
32. Cross S.E., and Roberts M.S. Use of in vitro human skin membranes to model and predict the effect of changing blood flow on the flux and retention of topically applied solutes. J Pharm Sci (2007) [Epub ahead of print]
33. Magnusson B.M., Anissimov Y.G., Cross S.E., et al. Molecular size as the main determinant of solute maximum flux across the skin. J Invest Dermatol 122 (2004) 993-999
34. Cordero J.A., Camacho M., Obach R., et al. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm 51 (2001) 135-142
35. Heyneman C.A., Lawless-Liday C., and Wall G.C. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs 60 (2000) 555-574
36. Brunner M., Dehghanyar P., Seigfried B., et al. Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation. Br J Clin Pharmacol 60 (2005) 573-577
37. Rolf C., Engström B., Beauchard C., et al. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology (Oxford) 38 (1999) 564-567
38. Radermacher J., Jentsch D., Scholl M.A., et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 31 (1991) 537-541
39. Hernández-Diaz S., and García Rodriguez L.A. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding and perforation: an overview of epidemiological studies published in the 1990s. Arch Intern Med 160 (2000) 2093-2099
40. Griffin M.R., Yared A., and Ray W.A. Nonsteroidal antiinflamatory drugs and acute renal failure in elderly persons. Am J Epidemiol 151 (2000) 488-496
41. Henry D., Page J., Whyte I., et al. Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects: results of a case-control study. Br J Clin Pharmacol 44 (1997) 85-90
42. Page J., and Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 160 (2000) 777-784
43. Heerdink E.R., Leufkens H.G., Herings R.M., et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 158 (1998) 1108-1112
44. United States Census Bureau. Available at:. http://www.census.gov/ Accessed February 29, 2008
45. Fraenkel L., Bogardus Jr. S.T., Concato J., et al. Treatment options in knee osteoarthritis: the patient's perspective. Arch Intern Med 164 (2004) 1299-1304
46. Underwood M., Ashby D., Cross P., et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ 336 (2008) 138-142
47. Eurek Alert! Available at:. http://www.eurekalert.org/pub_releases/2007-10/fi-vgr102107.php Accessed February 29, 2008